Table 1 Patients´ characteristics and statistics. a) Patients characteristics, antibody therapy and comedication. A comedication of several medication was possible. Comedication: A: amitriptyline, B: betablocker, T: topiramate, V: valproic acid, F: flunarizine, others: magnesium and other antidepressive drugs like selective serotonine reuptake inhibitors). b) changes in monthly headache days (MHD) and monthly migraine days (MMD) and monthly acute medication intake (AMD) after 3 months of treatment after the respective CGRP antibody therapie. MHD and MMD were significantly reduced after 3 months of treatment
